The Artery Is Not a Pipe. Plaque Is Not Just Cholesterol!

PLAQUE IS NOT JUST CHOLESTEROL. IT IS A PROCESS.

For a long time, atherosclerosis was explained in a very simple and intuitive way: we eat too much fat, blood cholesterol rises, cholesterol begins to accumulate along the walls of the arteries, the vessel gradually becomes “clogged,” and eventually a heart attack occurs.

It is an easy picture to understand because it resembles an old water pipe with deposits slowly building up along its inner surface. But a human artery is not a pipe. It is living, metabolically active tissue that continuously responds to blood flow, pressure, hormonal signals, inflammatory activity and the substances circulating in the bloodstream.

The same is true of atherosclerotic plaque. It is not simply a lump of fat stuck to the vessel wall. It is the result of a complex biological process that can develop over decades.

So if we want to understand cardiovascular risk properly, the conversation cannot begin and end with cholesterol. We also need to look at the arterial wall itself and the environment in which it exists.

It All Begins with the Endothelium

The inner surface of blood vessels is lined by an extremely thin layer of cells called the endothelium. It is only one cell layer thick, yet it performs an enormous number of functions.

The endothelium helps regulate vascular tone through nitric oxide, influences blood clotting, controls interactions between the blood and the vessel wall, and participates in immune signalling. When it functions normally, it is not merely a passive lining. It acts as an active protective interface between the blood and the arterial wall.

The problem begins when this protective layer is exposed to an unfavourable environment for years. Factors that can contribute to endothelial dysfunction through different mechanisms include:

• high blood pressure;
• smoking;
• chronically elevated blood glucose;
• insulin resistance;
• oxidative stress;
• chronic inflammation;
• environmental pollution;
• visceral obesity;
• chronic sleep deprivation.

As these factors accumulate, the biological environment within the vessel wall gradually changes. This is where the atherosclerotic process begins.

Plaque Does Not Simply Build Up on the Artery. It Develops Within the Arterial Wall.

This is one of the most important differences from the popular “clogged pipe” model.

Atherosclerotic plaque does not simply stick to the inner surface of the vessel. It begins to develop within the arterial wall itself.

When endothelial function is impaired, certain ApoB-containing lipoprotein particles can enter and become retained within the intima, the innermost layer of the artery. These include:

• LDL;
• VLDL remnants;
• IDL;
• Lp(a).

From this point onward, the process becomes much more complex than simple “cholesterol accumulation.” Retained lipoprotein particles can undergo various modifications, the endothelium becomes activated, and immune cells are recruited to the area.

Monocytes move into the arterial wall and differentiate into macrophages. These macrophages begin to take up modified lipoproteins and may gradually become foam cells – lipid-laden immune cells that are characteristic of early atherosclerotic lesions.

This is why plaque is not simply “cholesterol.” It can contain lipids, immune cells, vascular smooth muscle cells, connective tissue, calcium and cellular debris.

In other words, we are dealing with an active pathological structure, not a passive deposit of fat.

Inflammation Is Part of the Process

This connects directly with the broader topic of chronic inflammation.

Once again, inflammation is not simply something “bad” that the body has accidentally created. It is a response to a changed biological environment.

Macrophages do not enter the arterial wall without a reason. They are responding to material and signals that the body recognises as abnormal or potentially damaging. The problem is that when the stimulus persists for years, the immune response also persists.

More immune cells are recruited, inflammatory signalling molecules are released, and some foam cells die. Over time, this may contribute to the formation of a lipid-rich necrotic core. Vascular smooth muscle cells migrate into the area and produce collagen, helping form a fibrous cap over the lesion.

In practical terms, the body is trying to contain and stabilise the damaged area.

This illustrates an important principle:

The body is not trying to damage us. It is trying to limit the damage.

The Most Dangerous Plaque Is Not Always the Largest

When people think about atherosclerosis, it is natural to assume that the most dangerous artery is the one with the greatest degree of narrowing.

The reality is more complicated.

Some plaques may be relatively stable. They tend to have a thicker fibrous cap and may gradually narrow the vessel and reduce blood flow, while carrying a lower risk of sudden rupture.

Other plaques may contain a large lipid-rich necrotic core, active inflammation and a thinner fibrous cap. They may not even cause severe narrowing of the artery, yet they can be more vulnerable.

If such a plaque ruptures or its surface undergoes plaque erosion, platelets and the coagulation system can become rapidly activated. A blood clot – a thrombus – can then form.

The consequences depend on where this happens:

• if a coronary artery becomes occluded, a myocardial infarction (heart attack) may occur;
• if a similar process compromises cerebral circulation, it may result in an ischaemic stroke.

This changes how we should think about cardiovascular risk.

It is not only about how narrow the artery is. It is also about what is happening inside the arterial wall.

This Does Not Mean LDL Does Not Matter

When discussing inflammation, it is easy to swing to the opposite extreme and conclude that if inflammation is important, LDL must therefore be irrelevant.

That is not correct.

LDL particles have a normal physiological role: they transport lipids through the body. They are not “toxic” by definition.

However, the number of circulating atherogenic ApoB-containing particles matters because a greater number of particles creates more opportunities for them to interact with and become retained in the arterial wall.

That is why elevated ApoB is an important cardiovascular risk factor.

But ApoB is part of the system, not the entire system.

Imagine two people with the same LDL-C.

The first has normal blood pressure, good insulin sensitivity, does not smoke, has favourable body composition and a low inflammatory burden.

The second has hypertension, insulin resistance, visceral obesity, hyperglycaemia, smokes and has chronic low-grade inflammation.

One laboratory value may look similar.

The physiological environments are completely different.

This is why, at Agaia, we look not only at the marker itself, but also at the context in which that marker exists.

Why Is ApoB Such an Important Marker?

Standard LDL-C gives us an estimate of how much cholesterol is being carried within LDL particles.

But it does not directly tell us how many atherogenic particles are circulating.

ApoB brings us closer to answering that question.

Each atherogenic lipoprotein particle carries one molecule of apolipoprotein B, which means ApoB can serve as a marker of the total number of these particles.

This becomes especially important in certain metabolic conditions.

Two people may have similar LDL-C values, but in one person the cholesterol may be distributed among fewer particles, while the other may have a much larger number of circulating atherogenic particles.

From the perspective of the arterial wall, these are not equivalent situations.

Lp(a): A Risk Factor We Cannot Simply “Eat Away”

Lipoprotein(a), or Lp(a), is another important cardiovascular risk factor because its concentration is largely genetically determined.

A person can be lean, exercise regularly, eat well and have no diabetes, yet still have elevated Lp(a).

This is one reason why measuring Lp(a) at least once in adulthood can be useful, particularly in people with a family history of premature cardiovascular disease.

Lp(a) is an excellent example of why personalised assessment is more useful than universal advice.

Not all cardiovascular risk comes from lifestyle.

But when we know that a particular risk factor exists, we can manage the modifiable parts of the overall picture much more precisely.

The Metabolic Environment Is a Major Part of the Equation

Insulin resistance is a good example of why one lipid marker cannot tell the whole story.

It is often associated with a combination of:

• elevated triglycerides;
• lower HDL;
• increased VLDL production;
• impaired glucose regulation;
• increased visceral adiposity;
• higher blood pressure;
• chronic low-grade inflammation.

A person may not have dramatically elevated LDL-C and yet still have an unfavourable overall cardiometabolic profile.

This brings us back to a central Agaia principle:

Do not isolate the marker from the body that produced it.

High Blood Glucose Can Damage Arteries Through Its Own Mechanisms

Chronically elevated glucose is a problem independently of cholesterol.

It increases the glycation burden and contributes to the formation of advanced glycation end products – AGEs. These molecules can interact with receptors such as RAGE and activate oxidative and inflammatory signalling pathways.

This is one of the reasons diabetes is such a powerful cardiovascular risk factor.

The arterial wall is not exposed only to LDL.

It is continuously exposed to the entire biochemical environment of the blood – glucose, lipoproteins, hormones, inflammatory signals and products of oxidative stress.

All of them reach the same endothelium.

Blood Pressure Creates Mechanical Stress on the Vessel Wall

With every heartbeat, a pressure wave travels through the arterial system. When blood pressure remains chronically elevated, the mechanical load on the vessel wall increases as well.

This is particularly relevant at sites where arteries branch and blood flow becomes more complex. Atherosclerotic lesions often develop preferentially in such areas.

This reminds us that cardiovascular risk is not purely a matter of biochemistry.

It is also a matter of physics.

The arterial wall is constantly sensing how blood flows through it.

Smoking Is a Direct Assault on the Endothelium

If there is one cardiovascular risk factor where the message should be unequivocal, it is smoking.

Smoking:

• increases oxidative stress;
• impairs endothelial function;
• increases thrombotic risk;
• promotes an inflammatory environment;
• interacts adversely with other cardiovascular risk factors.

There is no supplement capable of compensating for this exposure.

What Does the Gut Have to Do with the Arteries?

More than it may seem at first.

The gut microbiome and intestinal barrier contribute to the regulation of the systemic immune and metabolic environment. When intestinal barrier function is impaired, certain bacterial components may gain greater access to the circulation and contribute to low-grade immune activation.

But it is important not to go to the opposite extreme.

Not every case of atherosclerosis means someone has “leaky gut,” and not every elevated CRP originates in the digestive system.

The gut is one of several systems that may be relevant and should be evaluated within the context of the individual.

A systems-based approach does not mean explaining everything through the gut. It means not leaving the gut out of the picture when it matters.

Sleep and Stress Reach the Arteries Too

Chronic sleep deprivation does more than make us feel tired the next day.

It can influence:

• glucose regulation;
• insulin sensitivity;
• appetite;
• blood pressure;
• autonomic nervous system function;
• inflammatory signalling.

The same applies to chronic psychophysiological stress. When the sympathetic nervous system keeps the body in a prolonged state of mobilisation, the vascular system functions within that same physiological environment.

That is why HRV, sleep quality, breathing and recovery are not simply peripheral “wellness” topics.

They are part of cardiometabolic health.

Movement Acts Across the Entire System

Few interventions can influence so many cardiovascular risk factors at the same time.

Regular aerobic physical activity can support:

• endothelial function;
• insulin sensitivity;
• blood pressure control;
• mitochondrial capacity;
• body composition;
• triglyceride levels;
• cardiorespiratory fitness.

Resistance training adds another valuable asset: skeletal muscle tissue.

Skeletal muscle is one of the major sites for glucose uptake and utilisation, which means muscle mass is not merely an aesthetic consideration.

It represents a metabolic reserve.

The same applies to VO₂max. It is far more than a sports-performance metric; it provides valuable information about the functional capacity of the cardiovascular and respiratory systems.

What Is Worth Measuring?

A standard lipid panel is a useful starting point, but in some people it should not be the end of the assessment.

Depending on age, medical history and individual cardiovascular risk, useful measures may include:

• LDL-C, HDL-C and triglycerides – the basic lipid profile;
• ApoB – for a better estimate of the number of atherogenic lipoprotein particles;
• Lp(a) – an important largely genetically determined risk factor;
• hs-CRP – information about systemic inflammatory activity, always interpreted in context;
• glucose, HbA1c and insulin – because metabolism and cardiovascular health are not separate systems within the human body;
• blood pressure – one of the most important and easiest cardiovascular variables to monitor regularly.

In appropriately selected people, imaging can provide another layer of information.

For example, Coronary Artery Calcium – CAC scoring can detect calcified coronary atherosclerosis and, in the appropriate clinical context, may meaningfully refine cardiovascular risk assessment.

There Is No “Anti-Plaque” Supplement

We can talk about omega-3 fatty acids, magnesium, vitamin D in the presence of deficiency, dietary nitrates, polyphenols and fibre. All of these may have a place within the right context.

But if someone simultaneously:

• smokes;
• sleeps five hours a night;
• has uncontrolled high blood pressure;
• has chronically elevated blood glucose;
• carries a significant amount of visceral fat;
• is almost completely sedentary,

it makes little sense to expect a single capsule to compensate for the entire physiological environment.

Supplements may be useful for addressing specific needs.

But the foundation remains physiology.

The Agaia Approach: We Do Not Look Only at Cholesterol. We Look at the Environment.

When assessing cardiovascular risk, the question should not simply be:

“What is your LDL?”

We want to see the broader picture:

• What is the person’s body composition?
• How much visceral fat do they carry?
• How well is blood glucose regulated?
• What is the insulin context?
• What are the triglyceride levels?
• What is the ApoB level?
• What is the Lp(a) level?
• Is there evidence of a systemic inflammatory burden?
• What is the blood pressure?
• Does the person smoke?
• How well do they sleep?
• How physically active are they?
• What is their VO₂max?
• What does their diet look like?
• How well are digestion and nutrient absorption functioning?
• Does the body have the nutrients required to support normal vascular function?

That begins to form a true physiological picture.

Not one isolated number, but the environment in which the arteries have to function every day.

The Artery Is Not a Pipe. It Is Living Tissue.

Perhaps this is the most important shift in how we should think about cardiovascular health.

Plaque does not appear overnight. A heart attack may seem sudden, but the biological process leading up to it usually develops over many years.

Years of uncontrolled high blood pressure, insulin resistance, smoking, increasing visceral fat, chronic sleep deprivation and insufficient physical activity may all contribute. Add to that genetic risks that may never have been measured and atherogenic lipoprotein particles interacting with this environment over decades.

That is why we do not need to choose between:

“Cholesterol is the problem.”

and

“Inflammation is the problem.”

Both statements oversimplify complex human biology when taken in isolation.

The more accurate picture is systemic:

Atherosclerosis is the result of interactions between atherogenic lipoproteins, the arterial wall, metabolism, the immune system, mechanical stress, genetics and lifestyle.

Prevention therefore needs to be systemic as well.

The goal is not simply to lower one laboratory value. It is to create an environment in which the arterial wall has as few reasons as possible to initiate and maintain the atherosclerotic process.

Because cardiovascular prevention does not begin when plaque is finally detected.

It begins years earlier – with the environment in which that plaque either can or cannot form.